Humanized Mouse Models for the Advancement of Innate Lymphoid Cell-Based Cancer Immunotherapies

Area of Science:

• Immunology
• Cancer Biology
• Innate Immunity

Background:

• Innate lymphoid cells (ILCs) are vital immune cells involved in homeostasis and antitumor responses.
• Understanding human natural killer (NK) cells and other ILCs in cancer is crucial for advancing cancer treatments.
• Significant differences exist between human and mouse ILC pathways, complicating preclinical research.

Purpose of the Study:

• To review the behavior of ILCs in cancer.
• To discuss humanized mouse models for studying tumor-ILC interactions.
• To explore strategies for manipulating ILCs for cancer immunotherapy.

Main Methods:

• Review of current literature on ILCs in cancer.
• Analysis of humanized mouse models used in cancer research.
• Evaluation of methods for enhancing ILC antitumor activity.

Main Results:

• Humanized mice provide valuable in vivo models for studying human ILCs in tumors.
• Recent advancements allow for detailed investigation of tumor-ILC dynamics.
• Various models show utility in assessing ILC-based immunotherapies.

Conclusions:

• Humanized mouse models are essential tools for understanding ILCs in cancer immunology.
• Optimized models are key for developing effective ILC-targeted cancer therapies.
• Further research in these models will advance cancer treatment strategies.